1. Home
  2. TTI vs TBPH Comparison

TTI vs TBPH Comparison

Compare TTI & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTI
  • TBPH
  • Stock Information
  • Founded
  • TTI 1981
  • TBPH 2013
  • Country
  • TTI United States
  • TBPH United States
  • Employees
  • TTI N/A
  • TBPH N/A
  • Industry
  • TTI Oil & Gas Production
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • TTI Energy
  • TBPH Health Care
  • Exchange
  • TTI Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • TTI 467.4M
  • TBPH 464.5M
  • IPO Year
  • TTI 1990
  • TBPH N/A
  • Fundamental
  • Price
  • TTI $2.50
  • TBPH $8.62
  • Analyst Decision
  • TTI Strong Buy
  • TBPH Buy
  • Analyst Count
  • TTI 3
  • TBPH 3
  • Target Price
  • TTI $6.67
  • TBPH $11.33
  • AVG Volume (30 Days)
  • TTI 1.5M
  • TBPH 222.8K
  • Earning Date
  • TTI 04-29-2025
  • TBPH 05-12-2025
  • Dividend Yield
  • TTI N/A
  • TBPH N/A
  • EPS Growth
  • TTI 311.87
  • TBPH N/A
  • EPS
  • TTI 0.82
  • TBPH N/A
  • Revenue
  • TTI $599,111,000.00
  • TBPH $64,381,000.00
  • Revenue This Year
  • TTI $8.58
  • TBPH $51.09
  • Revenue Next Year
  • TTI $10.67
  • TBPH N/A
  • P/E Ratio
  • TTI $2.91
  • TBPH N/A
  • Revenue Growth
  • TTI N/A
  • TBPH 12.12
  • 52 Week Low
  • TTI $2.03
  • TBPH $7.44
  • 52 Week High
  • TTI $5.12
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • TTI 36.59
  • TBPH 42.54
  • Support Level
  • TTI $2.24
  • TBPH $8.44
  • Resistance Level
  • TTI $2.44
  • TBPH $8.82
  • Average True Range (ATR)
  • TTI 0.25
  • TBPH 0.44
  • MACD
  • TTI -0.02
  • TBPH 0.00
  • Stochastic Oscillator
  • TTI 30.13
  • TBPH 55.47

About TTI Tetra Technologies Inc.

Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: